Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ABMT OTCMKTS:ADYX OTCMKTS:AKSY OTCMKTS:FSPKF On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABMTAdvanced Biomedical Technologies$0.00$0.00$0.00▼$0.00N/A1.48160 shsN/AADYXAlliqua BioMedical$0.00$0.00▼$0.00N/AN/AN/AN/AAKSYAksys$0.00$0.00▼$0.00N/AN/AN/AN/AFSPKFFisher & Paykel Healthcare$22.52$21.97$19.01▼$25.69N/AN/A3,365 shsN/A(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABMTAdvanced Biomedical Technologies0.00%0.00%0.00%0.00%+25.00%ADYXAlliqua BioMedical0.00%0.00%0.00%0.00%0.00%AKSYAksys0.00%0.00%0.00%0.00%0.00%FSPKFFisher & Paykel Healthcare0.00%0.00%0.00%-2.17%+1.90%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeABMTAdvanced Biomedical Technologies$0.00$0.00$0.00▼$0.00N/A1.48160 shsN/AADYXAlliqua BioMedical$0.00$0.00▼$0.00N/AN/AN/AN/AAKSYAksys$0.00$0.00▼$0.00N/AN/AN/AN/AFSPKFFisher & Paykel Healthcare$22.52$21.97$19.01▼$25.69N/AN/A3,365 shsN/A(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceABMTAdvanced Biomedical Technologies0.00%0.00%0.00%0.00%+25.00%ADYXAlliqua BioMedical0.00%0.00%0.00%0.00%0.00%AKSYAksys0.00%0.00%0.00%0.00%0.00%FSPKFFisher & Paykel Healthcare0.00%0.00%0.00%-2.17%+1.90%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceABMTAdvanced Biomedical Technologies 0.00N/AN/AN/AADYXAlliqua BioMedical 0.00N/AN/AN/AAKSYAksys 0.00N/AN/AN/AFSPKFFisher & Paykel Healthcare 2.00HoldN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookABMTAdvanced Biomedical TechnologiesN/AN/AN/AN/AN/AN/AADYXAlliqua BioMedicalN/AN/AN/AN/AN/AN/AAKSYAksysN/AN/AN/AN/AN/AN/AFSPKFFisher & Paykel HealthcareN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateABMTAdvanced Biomedical TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AN/AADYXAlliqua BioMedicalN/AN/AN/AN/AN/AN/AN/AN/AN/AAKSYAksysN/AN/AN/AN/AN/AN/AN/AN/AN/AFSPKFFisher & Paykel HealthcareN/A$0.17132.76N/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthABMTAdvanced Biomedical TechnologiesN/AN/AN/AN/AN/AADYXAlliqua BioMedicalN/AN/AN/AN/AN/AAKSYAksysN/AN/AN/AN/AN/AFSPKFFisher & Paykel Healthcare$0.070.29%N/A38.45%N/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipABMTAdvanced Biomedical TechnologiesN/AADYXAlliqua BioMedicalN/AAKSYAksysN/AFSPKFFisher & Paykel Healthcare31.42%Insider OwnershipCompanyInsider OwnershipABMTAdvanced Biomedical Technologies34.11%ADYXAlliqua BioMedical17.40%AKSYAksys3.80%FSPKFFisher & Paykel HealthcareN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableABMTAdvanced Biomedical Technologies20N/AN/ANot OptionableADYXAlliqua BioMedical6N/AN/ANot OptionableAKSYAksys87N/AN/ANot OptionableFSPKFFisher & Paykel Healthcare6,391N/AN/ANot OptionableFSPKF, ABMT, AKSY, and ADYX HeadlinesRecent News About These CompaniesFisher & Paykel Healthcare Corporation Limited (FSPKF) Q4 2026 Earnings Call TranscriptMay 25, 2026 | seekingalpha.comFisher & Paykel Healthcare Discloses Shareholding of New Director Anna CurzonApril 9, 2026 | theglobeandmail.comFisher & Paykel Healthcare seeing good growth across hospital productsFebruary 23, 2026 | msn.comSleep Aids: Trends, Technologies and Global Markets to 2030 Featuring Key Players Fisher & Paykel Healthcare, ResMed, Philips, Alphabet, Apple and MoreFebruary 20, 2026 | finance.yahoo.comFisher & Paykel Healthcare Corporation (FSPKF) price target increased by 33.37% to 24.19February 4, 2026 | msn.comAnalysts Offer Insights on Healthcare Companies: Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and Telix Pharmaceuticals (OtherTLPPF)January 29, 2026 | theglobeandmail.comF&P Healthcare names new board memberJanuary 22, 2026 | hmenews.comHFisher & Paykel added to APAC Conviction List at Goldman SachsDecember 1, 2025 | msn.comFisher & Paykel Healthcare Reports Record Revenue GrowthNovember 27, 2025 | msn.comF&P Healthcare reports ‘strong result’ in first halfNovember 27, 2025 | hmenews.comHAnalysts Are Bullish on These Healthcare Stocks: Fisher & Paykel Healthcare Corporation Limited (FSPKF), 3SBio (TRSBF)November 27, 2025 | theglobeandmail.comFisher & Paykel Healthcare Reports Strong First Half 2026 ResultsNovember 26, 2025 | msn.comFisher & Paykel Healthcare Corporation Limited (FSPKF) Q2 2026 Earnings Call TranscriptNovember 25, 2025 | seekingalpha.comIP Ones to Watch 2025: MIP recognises Jeremy Towers at Fisher & Paykel HealthcareOctober 1, 2025 | managingip.comMFisher & Paykel Healthcare Discloses Changes in Executive ShareholdingsSeptember 18, 2025 | msn.comFisher & Paykel Healthcare Discloses Executive Share Rights AdjustmentSeptember 6, 2025 | msn.comFisher & Paykel Healthcare Updates on Lapsed Share Options and RightsSeptember 5, 2025 | msn.comF&P reports ‘strong’ first halfAugust 22, 2025 | hmenews.comHFisher & Paykel Healthcare Projects Strong Growth and Announces Board ChangeAugust 20, 2025 | msn.comRBC cuts Fisher & Paykel stock rating, lowers price target to NZD29May 30, 2025 | uk.investing.comMedia Sentiment Over TimeFSPKF, ABMT, AKSY, and ADYX Company DescriptionsAdvanced Biomedical Technologies OTCMKTS:ABMT$0.0005 0.00 (0.00%) As of 07/2/2026Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.Alliqua BioMedical OTCMKTS:ADYXAdynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.Aksys OTCMKTS:AKSYAksys Ltd. provides hemodialysis products and services for patients suffering from end-stage renal disease, known as chronic kidney failure. The company offers an automated personal hemodialysis system, known as the Aksys PHD, a Personal Hemodialysis System (PHD System), which is designed to enable patients to perform frequent hemodialysis at alternate sites, such as their own homes. The PHD System is designed to monitor, during the treatment, various vital statistics, including the patient's blood flow rate, the amount of water removed from the patient, the length of the treatment session, and other parameters. It also evaluates the performance of the artificial kidney in removing toxins from the patient's blood prior to each treatment, as well as automatically evaluates the water treatment filters and indicates whether a replacement is required and verifies that safety systems, sensors, and alarms are operating correctly. Aksys Ltd. also provides various services, including the delivery and installation of the PHD System; technical services, including maintenance and repair of the PHD System; delivery of consumables used in dialysis, such as the water purification components and dialysate concentrate; and artificial kidney, and arterial and venous blood tubing. The company markets its products and services, primarily to healthcare providers, such as hospitals, dialysis clinics, managed care organizations, and nephrology physician groups in the United States, the United Kingdom, and Japan. Aksys Ltd. was founded in 1991 and is headquartered in Lincolnshire, Illinois.Fisher & Paykel Healthcare OTCMKTS:FSPKF$22.52 0.00 (0.00%) As of 07/2/2026Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/29 - 07/03 Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst This Under-the-Radar Industrial Is Quietly Powering AI SanDisk’s Volatility May Be Telling Bulls What They Want to Hear Broadcom and OpenAI Unveil Jalapeño: An Early Step to Massive AI Growth Potential Why the Comcast Spin-Off Won't Fix What's Actually Broken Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
